New Financing Methods in the Biopharma Industry: A Case Study of Royalty Pharma Inc.
The biotechnology and pharmaceutical industries are facing significant challenges to their existing business models because of expiring drug patents, declining risk tolerance of venture capitalists and other investors, and increasing complexity in translational medicine. In response to these challen...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Article |
| Language: | en_US |
| Published: |
Journal of Investment Management
2017
|
| Online Access: | http://hdl.handle.net/1721.1/109104 https://orcid.org/0000-0003-2944-7773 |